Vaccinating Boys Against Human Papillomavirus (HPV) Not Cost-Effective.
In a new study, Harvard School of Public Health (HSPH) researchers found that if vaccine coverage and efficacy are high in girls, a universal recommendation to vaccinate young boys is unlikely to provide comparatively good value for resources, compared with vaccinating girls only. The study was reported in the BMJ October 9..